These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17473287)

  • 21. Managing anemia: what do we do now?
    Neumann ME
    Nephrol News Issues; 2007 May; 21(6):50, 52. PubMed ID: 17518123
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythropoietic-stimulating agents (ESAs): new safety warning.
    Zarowitz BJ
    Geriatr Nurs; 2007; 28(3):148-50. PubMed ID: 17561012
    [No Abstract]   [Full Text] [Related]  

  • 23. EPO (epoetin) approval stirs cost concern in Congress.
    Wagner M
    Mod Healthc; 1989 Jun; 19(23):4. PubMed ID: 10293460
    [No Abstract]   [Full Text] [Related]  

  • 24. How safe are erythropoiesis-stimulating agents?
    Lichtin AE
    Cleve Clin J Med; 2008 May; 75(5):359-60. PubMed ID: 18556878
    [No Abstract]   [Full Text] [Related]  

  • 25. EPO--one year later. Fighting anemia in the courtroom.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
    [No Abstract]   [Full Text] [Related]  

  • 26. Anemia management in dialysis: Why the FDA and CMS have it right (and how KDIGO got it wrong).
    Coyne DW
    Nephrol News Issues; 2013 Feb; 27(2):16, 18, 20. PubMed ID: 23469454
    [No Abstract]   [Full Text] [Related]  

  • 27. Experts probe safety concerns of anemia drugs. Panelists call for more restrictions.
    Young D
    Am J Health Syst Pharm; 2007 Jun; 64(12):1244-6. PubMed ID: 17563039
    [No Abstract]   [Full Text] [Related]  

  • 28. New alternatives in anemia treatment: biosimilars and HIF stabilizers.
    Krishnan M; Nissenson AR
    Nephrol News Issues; 2014 May; 28(6):24-8. PubMed ID: 24908823
    [No Abstract]   [Full Text] [Related]  

  • 29. Catch a falling star: wonder drug EPO may be down, but not out.
    Neumann ME
    Nephrol News Issues; 2010 Sep; 24(10):8. PubMed ID: 20942325
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent changes to FDA-approved labeling.
    Am J Health Syst Pharm; 2004 Sep; 61(17):1766. PubMed ID: 15462244
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA approves Epoetin Alfa use for AZT patients.
    Nephrol News Issues; 1991 Apr; 5(4):11. PubMed ID: 1961277
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythropoietin in cancer-related anemia.
    Fenner MH; Ganser A
    Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of biosimilar epoetins in nephrology in the United States.
    Fishbane S; Shah HH
    Am J Kidney Dis; 2015 Apr; 65(4):537-42. PubMed ID: 25582283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers.
    AIDS Alert; 2002 Aug; 17(8):101-2. PubMed ID: 12647690
    [No Abstract]   [Full Text] [Related]  

  • 35. ESAs further restricted, but debate continues.
    Brower V
    J Natl Cancer Inst; 2008 Oct; 100(19):1344-51. PubMed ID: 18812542
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous erythropoietin receptor activator (Mircera) for renal anemia.
    McGahan L
    Issues Emerg Health Technol; 2008 Feb; (113):1-6. PubMed ID: 18354858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin: the swinging pendulum.
    Oster HS; Neumann D; Hoffman M; Mittelman M
    Leuk Res; 2012 Aug; 36(8):939-44. PubMed ID: 22579365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epoietin alfa (EPO) for anemia.
    Hanna L
    BETA; 1998 Jul; ():40, 42. PubMed ID: 11365562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA unveils risk-management program for ESAs.
    Traynor K
    Am J Health Syst Pharm; 2010 Apr; 67(7):508-9. PubMed ID: 20237374
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.